235 related articles for article (PubMed ID: 16375942)
1. Protection against rotavirus shedding after intranasal immunization of mice with a chimeric VP6 protein does not require intestinal IgA.
McNeal MM; Stone SC; Basu M; Bean JA; Clements JD; Hendrickson BA; Choi AH; Ward RL
Virology; 2006 Mar; 346(2):338-47. PubMed ID: 16375942
[TBL] [Abstract][Full Text] [Related]
2. Association of gamma interferon and interleukin-17 production in intestinal CD4+ T cells with protection against rotavirus shedding in mice intranasally immunized with VP6 and the adjuvant LT(R192G).
Smiley KL; McNeal MM; Basu M; Choi AH; Clements JD; Ward RL
J Virol; 2007 Apr; 81(8):3740-8. PubMed ID: 17251301
[TBL] [Abstract][Full Text] [Related]
3. Intrarectal immunization of mice with VP6 and either LT(R192G) or CTA1-DD as adjuvant protects against fecal rotavirus shedding after EDIM challenge.
McNeal MM; Basu M; Bean JA; Clements JD; Lycke NY; Ramne A; Löwenadler B; Choi AH; Ward RL
Vaccine; 2007 Aug; 25(33):6224-31. PubMed ID: 17629371
[TBL] [Abstract][Full Text] [Related]
4. The level of protection against rotavirus shedding in mice following immunization with a chimeric VP6 protein is dependent on the route and the coadministered adjuvant.
Choi AH; McNeal MM; Flint JA; Basu M; Lycke NY; Clements JD; Bean JA; Davis HL; McCluskie MJ; VanCott JL; Ward RL
Vaccine; 2002 Mar; 20(13-14):1733-40. PubMed ID: 11906760
[TBL] [Abstract][Full Text] [Related]
5. CD4 T cells are the only lymphocytes needed to protect mice against rotavirus shedding after intranasal immunization with a chimeric VP6 protein and the adjuvant LT(R192G).
McNeal MM; VanCott JL; Choi AH; Basu M; Flint JA; Stone SC; Clements JD; Ward RL
J Virol; 2002 Jan; 76(2):560-8. PubMed ID: 11752147
[TBL] [Abstract][Full Text] [Related]
6. Mice develop effective but delayed protective immune responses when immunized as neonates either intranasally with nonliving VP6/LT(R192G) or orally with live rhesus rotavirus vaccine candidates.
VanCott JL; Prada AE; McNeal MM; Stone SC; Basu M; Huffer B; Smiley KL; Shao M; Bean JA; Clements JD; Choi AH; Ward RL
J Virol; 2006 May; 80(10):4949-61. PubMed ID: 16641286
[TBL] [Abstract][Full Text] [Related]
7. Antibody-independent protection against rotavirus infection of mice stimulated by intranasal immunization with chimeric VP4 or VP6 protein.
Choi AH; Basu M; McNeal MM; Clements JD; Ward RL
J Virol; 1999 Sep; 73(9):7574-81. PubMed ID: 10438847
[TBL] [Abstract][Full Text] [Related]
8. Development of a Bacillus subtilis-based rotavirus vaccine.
Lee S; Belitsky BR; Brinker JP; Kerstein KO; Brown DW; Clements JD; Keusch GT; Tzipori S; Sonenshein AL; Herrmann JE
Clin Vaccine Immunol; 2010 Nov; 17(11):1647-55. PubMed ID: 20810679
[TBL] [Abstract][Full Text] [Related]
9. IFN-gamma is the only anti-rotavirus cytokine found after in vitro stimulation of memory CD4+ T cells from mice immunized with a chimeric VP6 protein.
McNeal MM; Stone SC; Basu M; Clements JD; Choi AH; Ward RL
Viral Immunol; 2007 Dec; 20(4):571-84. PubMed ID: 18158731
[TBL] [Abstract][Full Text] [Related]
10. Induction of immune responses and partial protection in mice after skin immunization with rotavirus VP6 protein and the adjuvant LT(R192G).
Choi AH; Smiley K; Basu M
Vaccine; 2005 Mar; 23(17-18):2290-3. PubMed ID: 15755613
[TBL] [Abstract][Full Text] [Related]
11. Intranasal or oral immunization of inbred and outbred mice with murine or human rotavirus VP6 proteins protects against viral shedding after challenge with murine rotaviruses.
Choi AH; McNeal MM; Basu M; Flint JA; Stone SC; Clements JD; Bean JA; Poe SA; VanCott JL; Ward RL
Vaccine; 2002 Sep; 20(27-28):3310-21. PubMed ID: 12213401
[TBL] [Abstract][Full Text] [Related]
12. Targeting of rotavirus VP6 to DEC-205 induces protection against the infection in mice.
Badillo-Godinez O; Gutierrez-Xicotencatl L; Plett-Torres T; Pedroza-Saavedra A; Gonzalez-Jaimes A; Chihu-Amparan L; Maldonado-Gama M; Espino-Solis G; Bonifaz LC; Esquivel-Guadarrama F
Vaccine; 2015 Aug; 33(35):4228-37. PubMed ID: 25850020
[TBL] [Abstract][Full Text] [Related]
13. Rotavirus 2/6 viruslike particles administered intranasally with cholera toxin, Escherichia coli heat-labile toxin (LT), and LT-R192G induce protection from rotavirus challenge.
O'Neal CM; Clements JD; Estes MK; Conner ME
J Virol; 1998 Apr; 72(4):3390-3. PubMed ID: 9525668
[TBL] [Abstract][Full Text] [Related]
14. Protective efficacy of rotavirus 2/6-virus-like particles combined with CT-E29H, a detoxified cholera toxin adjuvant.
Siadat-Pajouh M; Cai L
Viral Immunol; 2001; 14(1):31-47. PubMed ID: 11270595
[TBL] [Abstract][Full Text] [Related]
15. Immune responses elicited against rotavirus middle layer protein VP6 inhibit viral replication in vitro and in vivo.
Lappalainen S; Pastor AR; Tamminen K; López-Guerrero V; Esquivel-Guadarrama F; Palomares LA; Vesikari T; Blazevic V
Hum Vaccin Immunother; 2014; 10(7):2039-47. PubMed ID: 25424814
[TBL] [Abstract][Full Text] [Related]
16. Antibody-dependent and -independent protection following intranasal immunization of mice with rotavirus particles.
McNeal MM; Rae MN; Bean JA; Ward RL
J Virol; 1999 Sep; 73(9):7565-73. PubMed ID: 10438846
[TBL] [Abstract][Full Text] [Related]
17. Nasal immunization of mice with a rotavirus DNA vaccine that induces protective intestinal IgA antibodies.
García-Díaz A; López-Andújar P; Rodríguez Díaz J; Montava R; Torres Barceló C; Ribes JM; Buesa J
Vaccine; 2004 Dec; 23(4):489-98. PubMed ID: 15530697
[TBL] [Abstract][Full Text] [Related]
18. Identification of an immunodominant CD4+ T cell epitope in the VP6 protein of rotavirus following intranasal immunization of BALB/c mice.
McNeal MM; Basu M; Bean JA; Clements JD; Choi AH; Ward RL
Virology; 2007 Jul; 363(2):410-8. PubMed ID: 17337285
[TBL] [Abstract][Full Text] [Related]
19. Intradermal and intranasal immunizations with oligomeric middle layer rotavirus VP6 induce Th1, Th2 and Th17 T cell subsets and CD4
Heinimäki S; Malm M; Vesikari T; Blazevic V
Antiviral Res; 2018 Sep; 157():1-8. PubMed ID: 29935205
[TBL] [Abstract][Full Text] [Related]
20. Different profile and distribution of antigen specific T cells induced by intranasal and intrarectal immunization with rotavirus 2/6-VLP with and without LT-R192G.
Alkadah A; Thiam F; Mounier M; Charpilienne A; Poncet D; Kohli E; Basset C
Vaccine; 2013 Apr; 31(15):1924-30. PubMed ID: 23453731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
